Primary Open Angle African-American Glaucoma Genetics (POAAGG)
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
批准号:
8560079
负责人:
JOAN M O'BRIEN
金额:
$226.38万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
AdmixtureAffectAfricanAfrican AmericanAgeAgingAmericanAsiansBlindnessBlood specimenCaucasiansCaucasoid RaceClinicalCodeCollaborationsComorbidityComplexCorneaCustomDNADNA ResequencingDataData SetDemographic ImpactDevelopmentDiagnosisDiseaseDisease ProgressionDisease susceptibilityEnvironmentEpidemiologic StudiesFoundationsGenesGeneticGenotypeGlaucomaGoalsHealthInstitutionInvestigationKnowledgeMapsMedicalMeta-AnalysisMethodsModelingNerve DegenerationNeuronsOptic NerveOther GeneticsPatientsPennsylvaniaPharmaceutical PreparationsPhenotypePhysiologic Intraocular PressurePlayPopulationPopulation StudyPredispositionPrevalencePrimary Open Angle GlaucomaProteinsPublic HealthReportingResearchRetinaRetinal Ganglion CellsRiskRisk FactorsRoleSNP genotypingSamplingSeveritiesSpecialistSpecimenTestingThickTimeUnited StatesUniversitiesValidationVariantVisual Fieldsbaseblindburden of illnesscase controlcaucasian Americancell injurycohortendophenotypeexomegenetic analysisgenetic associationgenetic epidemiologygenetic risk factorgenetic variantgenome wide association studygenome-widenovelprogramspublic health relevanceretinal nerve fiber layerscreeningtrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
POAAGG Project Summary/Abstract
Glaucoma is the leading cause of irreversible blindness worldwide, affecting approximately
70 million people. By 2000, 2.2 million Americans had been diagnosed with glaucoma, and this
number is estimated to reach 3.4 million by 2020. Primary open angle glaucoma (POAG) is a
spectrum of disease causing vision loss which is associated with progressive and irreversible
degeneration of nerve cells in the retina. The prevalence of POAG is 3% among those of Asian
ancestry, 6% among Caucasians, and 16% among those of African ancestry age 70 and older.
POAG appears almost 10 years earlier and progresses more quickly in African Americans
(AAs), making it the leading cause of irreversible blindness in this population. Genetics are
known to play a role in this disease~ however, POAG genetics are complex, and many risk
factors are involved. This proposal represents the first large population study specifically
evaluating AAs for genetic risk factors.
In order to examine AAs for POAG risk factors, a genome wide association study (GWAS) will
be performed. GWAS is a method that detects genetic variants in a large population to
determine if any variants are associated with a disease or trait. The proposed GWAS will
generate data on these variants in 17,000 AAs, 2,000 with POAG and 15,000 controls. This
experimental approach will identify genes associated with POAG in AAs, who disproportionately
suffer from more severe forms of this disease. Many different clinical traits are associated with
POAG, and investigation of clinical determinants of this diagnosis will be correlated with genetic
data. Collaborations with other institutions that have explored this approach in other populations
will be used to further enhance the data set.
In addition to the GWAS, the portions of DNA responsible for coding proteins will be
specifically examined, since abnormal proteins are associated with disease susceptibility,
progression, and severity. Genetic risk factors for POAG have been identified in other
populations. The relevance of these known risk factors, along with new risk factors that emerge
from the proposed GWAS investigation, will be evaluated for Americans of African ancestry.
The ultimate goal of the Primary Open Angle African-American Glaucoma Genetics Study
(POAAGG) is to facilitate the development of rational, targeted screening, diagnosis and
eventually novel treatments for AA POAG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Primary Open Angle African-American Glaucoma Genetics Study Renewal
-
批准号:10400065
-
项目类别:
-
资助金额:$165.32万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics Study Renewal
-
批准号:10668949
-
项目类别:
-
资助金额:$142.03万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Primary Open Angle African-American Glaucoma Genetics (POAAGG)
-
批准号:8815318
-
项目类别:
-
资助金额:$221.32万
-
财政年份:2014
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6641270
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6910647
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7123301
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7250161
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:7082066
-
项目类别:
-
资助金额:$62.64万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6544745
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
Improved Ophthalmic Care for Retinoblastoma Patients
-
批准号:6765946
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2002
-
负责人:JOAN M O'BRIEN
-
依托单位:
海外基金